Efficient Specific DNA Binding by p53 Requires both Its Central and C-Terminal Domains as Revealed by Studies with High-Mobility Group 1 Protein

REFERENCES

• Ahn, J., and C. Prives. 2001. The C-terminus of p53: the more you learn the less you know. Nat. Struct. Biol. 8: 730–732.
   PubMedGoogle Scholar
• Anderson, M. E., B. Woelker, M. Reed, P. Wang, and P. Tegtmeyer. 1997. Reciprocal interference between the sequence-specific core and nonspecific C-terminal DNA binding domains of p53: implications for regulation. Mol. Cell. Biol. 17: 6255–6264.
   PubMed Web of Science ®Google Scholar
• Ayed, A., F. A. Mulder, G. S. Yi, Y. Lu, L. E. Kay, and C. H. Arrowsmith. 2001. Latent and active p53 are identical in conformation. Nat. Struct. Biol. 8: 756–760.
   PubMedGoogle Scholar
• Bakalkin, G., G. Selivanova, T. Yakovleva, E. Kiseleva, E. Kashuba, K. P. Magnusson, L. Szekely, G. Klein, L. Terenius, and K. G. Wiman. 1995. p53 binds single-stranded DNA ends through the C-terminal domain and internal DNA segments via the middle domain. Nucleic Acids Res. 23: 362–369.
   PubMed Web of Science ®Google Scholar
• Bakalkin, G., T. Yakovleva, G. Selivanova, K. P. Magnusson, L. Szekely, E. Kiseleva, G. Klein, L. Terenius, and K. G. Wiman. 1994. p53 binds single-stranded DNA ends and catalyzes DNA renaturation and strand transfer. Proc. Natl. Acad. Sci. USA 91: 413–417.
   PubMed Web of Science ®Google Scholar
• Balagurumoorthy, P., H. Sakamoto, M. S. Lewis, N. Zambrano, G. M. Clore, A. M. Gronenborn, E. Appella, and R. E. Harrington. 1995. Four p53 DNA-binding domain peptides bind natural p53-response elements and bend the DNA. Proc. Natl. Acad. Sci. USA 92: 8591–8595.
   PubMed Web of Science ®Google Scholar
• Barak, Y., T. Juven, R. Haffner, and M. Oren. 1993. mdm2 expression is induced by wild type p53 activity. EMBO J. 12: 461–468.
   PubMed Web of Science ®Google Scholar
• Barlev, N. A., L. Liu, N. H. Chehab, K. Mansfield, K. G. Harris, T. D. Halazonetis, and S. L. Berger. 2001. Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases. Mol. Cell 8: 1243–1254.
   PubMed Web of Science ®Google Scholar
• Bayle, J. H., B. Elenbaas, and A. J. Levine. 1995. The carboxyl-terminal domain of the p53 protein regulates sequence-specific DNA binding through its nonspecific nucleic acid-binding activity. Proc. Natl. Acad. Sci. USA 92: 5729–5733.
   PubMed Web of Science ®Google Scholar
• Boonyaratanakornkit, V., V. Melvin, P. Prendergast, M. Altmann, L. Ronfani, M. E. Bianchi, L. Taraseviciene, S. K. Nordeen, E. A. Allegretto, and D. P. Edwards. 1998. High-mobility group chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells. Mol. Cell. Biol. 18: 4471–4487.
   PubMed Web of Science ®Google Scholar
• Brickman, J. M., M. Adam, and M. Ptashne. 1999. Interactions between an HMG-1 protein and members of the Rel family. Proc. Natl. Acad. Sci. USA 96: 10679–10683.
   PubMedGoogle Scholar
• Bustin, M., and R. Reeves. 1996. High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. Prog. Nucleic Acid Res. Mol. Biol. 54: 35–100.
   Google Scholar
• Cain, C., S. Miller, J. Ahn, and C. Prives. 2000. The N terminus of p53 regulates its dissociation from DNA. J. Biol. Chem. 275: 39944–39953.
   PubMedGoogle Scholar
• Cherny, D. I., G. Striker, V. Subramaniam, S. D. Jett, E. Palecek, and T. M. Jovin. 1999. DNA bending due to specific p53 and p53 core domain-DNA interactions visualized by electron microscopy. J. Mol. Biol. 294: 1015–1026.
   PubMed Web of Science ®Google Scholar
• Decoville, M., M. J. Giraud-Panis, C. Mosrin-Huaman, M. Leng, and D. Locker. 2000. HMG boxes of DSP1 protein interact with the rel homology domain of transcription factors. Nucleic Acids Res. 28: 454–462.
   PubMedGoogle Scholar
• Dudenhoffer, C., G. Rohaly, K. Will, W. Deppert, and L. Wiesmuller. 1998. Specific mismatch recognition in heteroduplex intermediates by p53 suggests a role in fidelity control of homologous recombination. Mol. Cell. Biol. 18: 5332–5342.
   PubMedGoogle Scholar
• el-Deiry, W. S. 1998. Regulation of p53 downstream genes. Semin. Cancer Biol. 8: 345–357.
   PubMed Web of Science ®Google Scholar
• el-Deiry, W. S., S. E. Kern, J. A. Pietenpol, K. W. Kinzler, and B. Vogelstein. 1992. Definition of a consensus binding site for p53. Nat. Genet. 1: 45–49.
   PubMed Web of Science ®Google Scholar
• el-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817–825.
   PubMed Web of Science ®Google Scholar
• Espinosa, J. M., and B. M. Emerson. 2001. Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment. Mol. Cell 8: 57–69.
   PubMed Web of Science ®Google Scholar
• Friedlander, P., Y. Legros, T. Soussi, and C. Prives. 1996. Regulation of mutant p53 temperature-sensitive DNA binding. J. Biol. Chem. 271: 25468–25478.
   PubMed Web of Science ®Google Scholar
• Gu, W., and R. G. Roeder. 1997. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90: 595–606.
   PubMed Web of Science ®Google Scholar
• Hainaut, P., and M. Hollstein. 2000. p53 and human cancer: the first ten thousand mutations. Adv. Cancer Res. 77: 81–137.
   PubMed Web of Science ®Google Scholar
• Halazonetis, T. D., and A. N. Kandil. 1993. Conformational shifts propagate from the oligomerization domain of p53 to its tetrameric DNA binding domain and restore DNA binding to select p53 mutants. EMBO J. 12: 5057–5064.
   PubMedGoogle Scholar
• Hansen, S., T. R. Hupp, and D. P. Lane. 1996. Allosteric regulation of the thermostability and DNA binding activity of human p53 by specific interacting proteins. CRC Cell Transformation Group. J. Biol. Chem. 271: 3917–3924.
   PubMed Web of Science ®Google Scholar
• Hupp, T. R., D. W. Meek, C. A. Midgley, and D. P. Lane. 1992. Regulation of the specific DNA binding function of p53. Cell 71: 875–886.
   PubMed Web of Science ®Google Scholar
• Hupp, T. R., A. Sparks, and D. P. Lane. 1995. Small peptides activate the latent sequence-specific DNA binding function of p53. Cell 83: 237–245.
   PubMed Web of Science ®Google Scholar
• Imamura, T., H. Izumi, G. Nagatani, T. Ise, M. Nomoto, Y. Iwamoto, and K. Kohno. 2001. Interaction with p53 enhances binding of cisplatin-modified DNA by high mobility group 1 protein. J. Biol. Chem. 276: 7534–7540.
   PubMed Web of Science ®Google Scholar
• Jayaraman, L., and C. Prives. 1995. Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus. Cell 81: 1021–1029.
   PubMed Web of Science ®Google Scholar
• Jayaraman, L., E. Freulich, and C. Prives. 1997. Functional dissection of p53 tumor suppressor protein. Methods Enzymol. 283: 245–256.
   PubMedGoogle Scholar
• Jayaraman, L., N. C. Moorthy, K. G. Murthy, J. L. Manley, M. Bustin, and C. Prives. 1998. High mobility group protein-1 (HMG-1) is a unique activator of p53. Genes Dev. 12: 462–472.
   PubMed Web of Science ®Google Scholar
• Jayaraman, L., and C. Prives. 1999. Covalent and noncovalent modifiers of the p53 protein. Cell Mol. Life Sci. 55: 76–87.
   PubMed Web of Science ®Google Scholar
• Jimenez, G. S., M. Nister, J. M. Stommel, M. Beeche, E. A. Barcarse, X. Q. Zhang, S. O'Gorman, and G. M. Wahl. 2000. A transactivation-deficient mouse model provides insights into Trp53 regulation and function. Nat. Genet. 26: 37–43.
   PubMed Web of Science ®Google Scholar
• Kaeser, M. D., and R. D. Iggo. 2002. From the cover: chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity invivo. Proc. Natl. Acad. Sci. USA 99: 95–100.
   PubMed Web of Science ®Google Scholar
• Kastan, M. B., Q. Zhan, W. S. el-Deiry, F. Carrier, T. Jacks, W. V. Walsh, B. S. Plunkett, B. Vogelstein, and A. J. Fornace, Jr. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71: 587–597.
   PubMed Web of Science ®Google Scholar
• Kim, E., N. Albrechtsen, and W. Deppert. 1997. DNA-conformation is an important determinant of sequence-specific DNA binding by tumor suppressor p53. Oncogene 15: 857–869.
   PubMed Web of Science ®Google Scholar
• Kim, E., G. Rohaly, S. Heinrichs, D. Gimnopoulos, H. Meissner, and W. Deppert. 1999. Influence of promoter DNA topology on sequence-specific DNA binding and transactivation by tumor suppressor p53. Oncogene 18: 7310–7318.
   PubMed Web of Science ®Google Scholar
• Ko, L. J., and C. Prives. 1996. p53: puzzle and paradigm. Genes Dev. 10: 1054–1072.
   PubMed Web of Science ®Google Scholar
• Lee, S., L. Cavallo, and J. Griffith. 1997. Human p53 binds Holliday junctions strongly and facilitates their cleavage. J. Biol. Chem. 272: 7532–7539.
   PubMedGoogle Scholar
• Lee, S., B. Elenbaas, A. Levine, and J. Griffith. 1995. p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches. Cell 81: 1013–1020.
   PubMed Web of Science ®Google Scholar
• Lehming, N., A. Le Saux, J. Schuller, and M. Ptashne. 1998. Chromatin components as part of a putative transcriptional repressing complex. Proc. Natl. Acad. Sci. USA 95: 7322–7326.
   PubMed Web of Science ®Google Scholar
• Levine, A. J. 1997. p53, the cellular gatekeeper for growth and division. Cell 88: 323–331.
   PubMed Web of Science ®Google Scholar
• Miyashita, T., and J. C. Reed. 1995. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80: 293–299.
   PubMed Web of Science ®Google Scholar
• Murphy, F. V. T., R. M. Sweet, and M. E. Churchill. 1999. The structure of a chromosomal high mobility group protein-DNA complex reveals sequence-neutral mechanisms important for non-sequence-specific DNA recognition. EMBO J. 18: 6610–6618.
   PubMed Web of Science ®Google Scholar
• Nagaich, A. K., E. Appella, and R. E. Harrington. 1997. DNA bending is essential for the site-specific recognition of DNA response elements by the DNA binding domain of the tumor suppressor protein p53. J. Biol. Chem. 272: 14842–14849.
   PubMed Web of Science ®Google Scholar
• Nagaich, A. K., V. B. Zhurkin, S. R. Durell, R. L. Jernigan, E. Appella, and R. E. Harrington. 1999. p53-induced DNA bending and twisting: p53 tetramer binds on the outer side of a DNA loop and increases DNA twisting. Proc. Natl. Acad. Sci. USA 96: 1875–1880.
   PubMed Web of Science ®Google Scholar
• Nagaich, A. K., V. B. Zhurkin, H. Sakamoto, A. A. Gorin, G. M. Clore, A. M. Gronenborn, E. Appella, and R. E. Harrington. 1997. Architectural accommodation in the complex of four p53 DNA binding domain peptides with the p21/waf1/cip1 DNA response element. J. Biol. Chem. 272: 14830–14841.
   PubMed Web of Science ®Google Scholar
• Nie, Y., H. H. Li, C. M. Bula, and X. Liu. 2000. Stimulation of p53 DNA binding by c-Abl requires the p53 C terminus and tetramerization. Mol. Cell. Biol. 20: 741–748.
   PubMed Web of Science ®Google Scholar
• Okamoto, K., and D. Beach. 1994. Cyclin G is a transcriptional target of the p53 tumor suppressor protein. EMBO J. 13: 4816–4822.
   PubMed Web of Science ®Google Scholar
• Paull, T. T., M. J. Haykinson, and R. C. Johnson. 1993. The nonspecific DNA-binding and -bending proteins HMG1 and HMG2 promote the assembly of complex nucleoprotein structures. Genes Dev. 7: 1521–1534.
   PubMedGoogle Scholar
• Perry, M. E., J. Piette, J. A. Zawadzki, D. Harvey, and A. J. Levine. 1993. The mdm-2 gene is induced in response to UV light in a p53-dependent manner. Proc. Natl. Acad. Sci. USA 90: 11623–11627.
   PubMed Web of Science ®Google Scholar
• Pil, P. M., C. S. Chow, and S. J. Lippard. 1993. High-mobility-group 1 protein mediates DNA bending as determined by ring closures. Proc. Natl. Acad. Sci. USA 90: 9465–9469.
   PubMedGoogle Scholar
• Reed, M., B. Woelker, P. Wang, Y. Wang, M. E. Anderson, and P. Tegtmeyer. 1995. The C-terminal domain of p53 recognizes DNA damaged by ionizing radiation. Proc. Natl. Acad. Sci. USA 92: 9455–9459.
   PubMed Web of Science ®Google Scholar
• Sakaguchi, K., J. E. Herrera, S. Saito, T. Miki, M. Bustin, A. Vassilev, C. W. Anderson, and E. Appella. 1998. DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev. 12: 2831–2841.
   PubMed Web of Science ®Google Scholar
• Stros, M. 1998. DNA bending by the chromosomal protein HMG1 and its high mobility group box domains. Effect of flanking sequences. J. Biol. Chem. 273: 10355–10361.
   PubMedGoogle Scholar
• Stros, M., and J. Reich. 1998. Formation of large nucleoprotein complexes upon binding of the high-mobility-group (HMG) box B-domain of HMG1 protein to supercoiled DNA. Eur. J. Biochem. 251: 427–434.
   PubMedGoogle Scholar
• Takenaka, I., F. Morin, B. R. Seizinger, and N. Kley. 1995. Regulation of the sequence-specific DNA binding function of p53 by protein kinase C and protein phosphatases. J. Biol. Chem. 270: 5405–5411.
   PubMed Web of Science ®Google Scholar
• Thomas, J. O., and A. A. Travers. 2001. HMG1 and 2, and related ′architectural' DNA-binding proteins. Trends Biochem. Sci. 26: 167–174.
   PubMed Web of Science ®Google Scholar
• Vogelstein, B., D. Lane, and A. J. Levine. 2000. Surfing the p53 network. Nature 408: 307–310.
   PubMed Web of Science ®Google Scholar
• Wang, Y., and C. Prives. 1995. Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases. Nature 376: 88–91.
   PubMed Web of Science ®Google Scholar
• Watt, F., and P. L. Molloy. 1988. High mobility group proteins 1 and 2 stimulate binding of a specific transcription factor to the adenovirus major late promoter. Nucleic Acids Res. 16: 1471–1486.
   PubMedGoogle Scholar
• Wu, X., J. H. Bayle, D. Olson, and A. J. Levine. 1993. The p53-mdm-2 autoregulatory feedback loop. Genes Dev. 7: 1126–1132.
   PubMed Web of Science ®Google Scholar
• Yakovleva, T., A. Pramanik, T. Kawasaki, K. Tan-No, I. Gileva, H. Lindegren, U. Langel, T. J. Ekstrom, R. Rigler, L. Terenius, and G. Bakalkin. 2001. p53 latency. C-terminal domain prevents binding of p53 core to target but not to nonspecific DNA sequences. J. Biol. Chem. 276: 15650–15658.
   PubMedGoogle Scholar
• Yu, J., L. Zhang, P. M. Hwang, C. Rago, K. W. Kinzler, and B. Vogelstein. 1999. Identification and classification of p53-regulated genes. Proc. Natl. Acad. Sci. USA 96: 14517–14522.
   PubMed Web of Science ®Google Scholar
• Zappavigna, V., L. Falciola, M. Helmer-Citterich, F. Mavilio, and M. E. Bianchi. 1996. HMG1 interacts with HOX proteins and enhances their DNA binding and transcriptional activation. EMBO J. 15: 4981–4991.
   PubMed Web of Science ®Google Scholar
• Zhao, R., K. Gish, M. Murphy, Y. Yin, D. Notterman, W. H. Hoffman, E. Tom, D. H. Mack, and A. J. Levine. 2000. Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. Genes Dev. 14: 981–993.
   PubMedGoogle Scholar
• Zotchev, S. B., M. Protopopova, and G. Selivanova. 2000. p53 C-terminal interaction with DNA ends and gaps has opposing effect on specific DNA binding by the core. Nucleic Acids Res. 28: 4005–4012.
   PubMedGoogle Scholar
• Zwilling, S., H. Konig, and T. Wirth. 1995. High mobility group protein 2 functionally interacts with the POU domains of octamer transcription factors. EMBO J. 14: 1198–1208.
   PubMedGoogle Scholar